Levi & Korsinsky Announces Viewray Class Action Investigation; VRAY Lawsuit

Class Action Reports

Levi & Korsinsky Announces Viewray Class Action Investigation; VRAY Lawsuit

Levi & Korsinsky, LLP

September 24, 2019

Levi & Korsinsky, LLP announces that a VRAY class action lawsuit has been commenced on behalf of investors who purchased Viewray, Inc. (VRAY) securities between March 15, 2019 and August 8, 2019. For more on the Viewray Class Action please contact us today.

According to the Viewray lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) demand for ViewRay systems had declined due in part to changes being made to Medicare reimbursement approaches first announced in November 2019 that could make purchases of new ViewRay systems less profitable for customers; (2) the Company’s reported backlog was overstated due to the inclusion of orders with insufficient surety as to permit for their inclusion in reported backlog; and (3) as a result of the foregoing, defendants’ positive statements about ViewRay’s business metrics and financial prospects during the Class Period were materially false and misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE VRAY CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/viewray-inc-loss-form?prid=3551&wire=1

If you suffered a loss in Viewray you have until November 12, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.



Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006


Tel: (212) 363-7500

Fax: (212) 363-7171